Allergan, SonarMD to develop cloud-based engagement platform for IBD patients

Allergan and SonarMD have partnered to develop clinical decision support and patient engagement tools to diagnose and manage patients with a form of irritable bowel syndrome.

Advertisement

By using this engagement platform, physicians will be able to monitor patients suffering from irritable bowel syndrome with diarrhea. The platform’s services will include assessments of symptoms and treatment impact. Allergan and SonarMD say that the platform will also help to generate real-world data on the effects of various treatment options.

SonarMD has already developed a cloud-based care management platform for patients with other chronic illnesses, such as Crohn’s disease. This platform was created by gastroenterologist Lawrence Kosinski, MD.

More articles on patient engagement:
AnMed Health implements patient education technology, sees rise in HCAHPS scores
Penn State Children’s hospital hires furry new employee to help patients relieve stress
Multisensory education improves patient understanding

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Experience

Advertisement

Comments are closed.